Single dose versus multiple doses of rituximab for preemptive therapy of Epstein-Barr virus reactivation after hematopoietic cell transplantation.
Jain T, Kosiorek HE, Grys TE, Kung STing, Shah VS, Betcher JA, Slack JL, Leis JF, Khera N, Noel P, et al. Single dose versus multiple doses of rituximab for preemptive therapy of Epstein-Barr virus reactivation after hematopoietic cell transplantation. Leuk Lymphoma. 2018:1-8.